Filtered By:
Source: Mass Device
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 467 results found since Jan 2013.
Pulse Therapeutics brings in $1M for stroke treatment
Pulse Therapeutics closes in on a $1.5 million fundraising goal, having so far raised a little over $1 million.
Pulse Therapeutics is nearing its $1.5 million goal in an active fundraising effort that has so far brought in just over $1 million, according to a SEC filing.
St. Louis-based Pulse Therapeutics is developing stroke treatment technologies based on tiny, biologically safe iron particles that could deliver drug therapy.
Pulse TherapeuticsNews Well, Funding Roundup, Neurologicalread more
Source: Mass Device - February 19, 2014 Category: Medical Equipment Authors: Chris Walker Source Type: news
Medtronic's Reveal XT bests standard care for heart monitoring in stroke patients
Medtronic's Reveal XT continuous heart monitor detected atrial fibrillation more often than current standards of care, including electrocardiograms and short-term diagnostic tests.
Results from Medtronic's (NYSE:MDT) CRYSTAL AF clinical trial found that the company's tiny Reveal XT continuous monitor performed better at detecting heart problems in stroke patients than current standards of care, the company reported.
MedtronicNews Well, Clinical Trials, Cardiac Rhythm Management, Minnesota, Patient Monitoring, Remote Patient Monitoringread more
Source: Mass Device - February 20, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
New apps help manage stroke care, identify seizures | MassDevice.com On Call
A pair of studies released at this week's American Academy of Neurology meeting highlight smartphone apps that aim to help doctors manage care for acute stroke patients and the public identify epileptic seizures.
MASSDEVICE ON CALL — Neurologists this week unveiled studies for a pair of smartphone apps that could help patients suffering seizures or strokes.
American Academy of NeurologyNews Well, On Call, mHealth (Mobile Health), Neurologicalread more
Source: Mass Device - February 21, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
Study: AliveCor's mobile ECG helps discover hidden stroke risk
AliveCor touts positive results from its SEARCH-AF study, saying its smartphone ECG reader helped uncover hidden atrial fibrillation in asymptomatic patients who may be at high risk of stroke.
Smartphone-based community ECG readings may help save lives as well as healthcare dollars, according to a study unveiled by mobile health company AliveCor.
AliveCorNews Well, Clinical Trials, Cardiac Rhythm Management, mHealth (Mobile Health), Strokeread more
Source: Mass Device - April 3, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device
The FDA wants to convene another advisory panel on Boston Scientific's Watchman anti-stroke heart repair device, CFO Dan Brennan told investors today in Boston, saying the development pushes the approval timeline into 2015.
Boston Scientific, Food & Drug Administration (FDA)News Well, Cardiac Implants, Regulatory/Compliance, Wall Street Beatread more
Source: Mass Device - June 17, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news
Boston Scientific lands another date with FDA panel for Watchman stroke device
An FDA advisory panel is slated to convene yet again in October to consider the safety and efficacy of Boston Scientific's Watchman anti-stroke heart repair device.
Boston Scientific, Food & Drug Administration (FDA)News Well, Cardiac Implants, Pre-Market Approval (PMA), Regulatory/Complianceread more
Source: Mass Device - August 26, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news
Press Release: REVIVE SE thrombectomy device approved for ischemic stroke patients in China, South Korea and Taiwan
Codman Neuro expands global footprint in Asia Pacific.
Codman Neuro, DePuy SynthesNews Well, Press Release, Regulatory/Clearance, Stroke, Vascularread more
Source: Mass Device - September 8, 2014 Category: Medical Equipment Authors: MassDevice Source Type: news
Mr. Clean: Device makers jump on positive thrombectomy results in stroke trial
Medical device makers are jumping on the bandwagon of the Mr. Clean trial showing that thrombectomy is superior to medical treatment in cases of severe ischemic stroke.
Covidien, New England Journal of Medicine, Penumbra Inc., Stryker Corp.News Well, Clinical Trials, Strokeread more
Source: Mass Device - December 17, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news
FDA OKs Silk Road Medical's anti-stroke Enroute device
The FDA says it cleared the Enroute transcarotid neuroprotection device made by Silk Road Medical.
The FDA today said it granted 510(k) clearance to the anti-stroke Enroute device made by Silk Road Medical.
Food & Drug Administration (FDA), Silk Road Medical Inc.News Well, 510(k), Regulatory/Compliance, Stents, Strokeread more
Source: Mass Device - February 9, 2015 Category: Medical Equipment Authors: Brad Perriello Source Type: news
FDA approves Boston Scientific's Watchman anti-stroke device
Six years after an FDA panel 1st recommended approval, the safety watchdog grants pre-market approval to Boston Scientific's Watchman anti-stroke cardiac implant.
Boston Scientific, Food & Drug Administration (FDA)News Well, Cardiac Implants, Pre-Market Approval (PMA)read more
Source: Mass Device - March 16, 2015 Category: Medical Equipment Authors: Brad Perriello Source Type: news
HeartWare slides on stroke results from heart pump studies
Higher-than-expected stroke rates reported in a pair of studies of HeartWare's implantable heart pump this week spook investors, pushing HTWR share prices down more than 8%.
HeartWare International Inc., Thoratec Corp.News Well, Clinical Trials, Cardiac Assist Devicesread more
Source: Mass Device - April 16, 2015 Category: Medical Equipment Authors: Brad Perriello Source Type: news
Silk Road Medical raises $57 million
Silk Road Medical today said it reeled in a $57 million equity-and-debt round from a group of new and existing backers.
Sunnyvale, Calif.-based Silk Road, which makes the Enroute transcarotid artery stent and neuroprotection system, said CRG led the debt round and participated in the equity portion, joined by prior investors Warburg Pincus and The Vertical Group.
“The strength of this financing is a testament to the large opportunity we have to solve unmet clinical needs and lead the next endovascular revolution with TCAR,” CEO Erica Rogers said in prepared remarks. “Our proprietary advances in tempo...
Source: Mass Device - October 20, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Stents Vascular Silk Road Medical Inc. Stroke Source Type: news
Keystone Heart, Venus Medtech ink Asian TAVR stroke partnership deal
Keystone Heart and Chinese heart valve maker Venus Medtech said today they inked a partnership deal covering China and other Asian markets.
Through the deal, the companies will provide Venus Medtech’s transcatheter aortic valve replacement system along with Keystone’s TriGuard cerebral embolic protection device.
TriGuard is a cerebral embolic protection device designed to reduce the amount of embolic material entering blood circulation to the brain during TAVR procedures, by allowing blood to pass through while catching potentially dangerous embolic debris.
“Providing brain protection for every TAVR pat...
Source: Mass Device - March 2, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular Catheters Replacement Heart Valves Keystone Heart Venus Medtech Source Type: news
Study: New infrared imaging technique could help detect heart attack, stroke risk
A new near-infrared diagnostic technique could help improve early detection for patients at risk of heart attacks or strokes, according to a new multi-center study.
Researchers at the University of Warwick’s WMG, the Baker Institute and Monash University reported that when they increased the wavelength of light currently used to visualize athereosclerotic plaques, they were able to selectively identify rupture-prone deposits, which can lead to blood clots, heart attacks and strokes.
Data from a study of the technique was published in the journal Nature Communications.
Current imaging techniques are able to identify c...
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Research & Development Source Type: news
InspireMD touts results of ‘one-size-fits-all’ stroke-prevention study
InspireMD’s CGuard embolic prevention stent
A clinical trial of InspireMD’s (NYSE:NSPR) CGuard embolic prevention stent showed that it successfully treated patients whose carotid arteries varied in size, according to the company.
The investigator-initiated trial in Germany used a 10 mm diameter CGuard stent with SmartFit technology across a broad range of carotid artery diameters. Variations in diameters of the common carotid artery (CCA) and the internal carotid artery (ICA), as well as inaccurate x-ray images caused by projection angles, make choosing the correct size choice of a carotid stent challenging, a...
Source: Mass Device - January 28, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Implants Neurological News Well Research & Development Stents InspireMD Source Type: news
